摘要

It is critical to assess the degree of liver fibrosis for clinical management. However, liver biopsy has many drawbacks and is invasive. Promising non-invasive methods including serum markers and new imaging studies to predict liver fibrosis have been developed in past decades. This editorial provides a succinct overview and update of the new non-invasive technologies, especially the three-dimensional magnetic resonance imaging (3-D MRI) that has been studied by Dr. Kawamura's group in Japan. It also highlights the merit and weakness of this 3D-MRI technology in predicting liver fibrosis and indicates future studies to understand where 3D-MRI fits into the current armamentarium of non-invasive serum-based and imaging technologies.

  • 出版日期2013-7

全文